1AD
Click for more information
0.00% 2.5¢ adalta limited

Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-14

  1. debono
    23,034 Posts.
    lightbulb Created with Sketch. 827
    clock Created with Sketch.
    08/04/24
    12:44
    Post #: 73238459
    Looking forward to this.

    AdAlta's (ASX:1AD) CEO and MD, Tim Oldham will host a webinar to discuss AdAlta’s new collaboration with SYNthesis BioVentures under a Memorandum of Understanding announced on Monday 8 April 2024 and general business progress | Register https://us02web.zoom.us/webinar/register/WN_86kBPnJVTja6QmLsty2i7Q#/registration… #1AD #Webinar
    1AD Price at posting: 3.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IDA Indiana Resources to win US$90M from Tanzania following international lawsuit
right-arrow Created with Sketch.
BC8 Black Cat Syndicate one pour away from being rerated as producer
right-arrow Created with Sketch.
NEWS Training with professional athletes: How to invest like the best
right-arrow Created with Sketch.
ARU Arafura updates gas supply agreement with Mereenie JV for 16.4PJ supply to Nolans REE play
right-arrow Created with Sketch.
DEG De Grey sees more production at Hemi with latest drilling at Crow, Aquila
right-arrow Created with Sketch.
NVA Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $14.89M
Open High Low Value Volume
2.5¢ 2.5¢ 2.5¢ $9.266K 370.6K

Buyers (Bids)

No. Vol. Price($)
3 174960 2.4¢
 

Sellers (Offers)

Price($) Vol. No.
2.5¢ 300000 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.